Internal radiotherapy of painful bone metastases

Methods

Volumn 55, Issue 3, 2011, Pages 258-270

  Liepe, K ^a   Kotzerke, J ^b  

^a UNIVERSITY OF KASSEL   (Germany)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

117mTin DTPA; 153Sm EDTMP; 186Re HEDP; 188Re HEDP; 233Ra; 89Sr; Painful bone metastasis

Indexed keywords

ACETYLSALICYLIC ACID; AMINO TERMINAL TELOPEPTIDE; ANTIANDROGEN; BISPHOSPHONIC ACID DERIVATIVE; CLODRONIC ACID; CODEINE; DIHYDROMORPHINE; ESTROGEN; FENTANYL; GONADORELIN; IBANDRONIC ACID; IBUPROFEN; MORPHINE; NAPROXEN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PAMIDRONIC ACID; PHENOTHIAZINE; PLACEBO; PROGESTERONE; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT; RADIOSENSITIZING AGENT; RHENIUM; STRONTIUM CHLORIDE; TAMOXIFEN; TESTOSTERONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; ZOLEDRONIC ACID;

ANEMIA; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; AUTOLOGOUS STEM CELL TRANSPLANTATION; BLOOD CELL COUNT; BONE MARROW TOXICITY; BONE METASTASIS; BONE PAIN; BREAST CANCER; BREAST FEEDING; BRIEF PAIN INVENTORY; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER HORMONE THERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CASTRATION; CHEMOSENSITIZATION; COMPARATIVE STUDY; CONFUSION; CONSTIPATION; DISEASE COURSE; DISEASE FREE SURVIVAL; DOSIMETRY; DRUG EFFICACY; EARLY CANCER; ELECTRON; EXTERNAL BEAM RADIOTHERAPY; EXTRACELLULAR MATRIX; FOLLOW UP; GLOMERULUS FILTRATION RATE; HALLUCINATION; HEMIBODY RADIOTHERAPY; HUMAN; INTERNAL RADIOTHERAPY; INTRACTABLE PAIN; KARNOFSKY PERFORMANCE STATUS; LEUKOPENIA; LIFE EXPECTANCY; MCGILL PAIN QUESTIONNAIRE; META ANALYSIS (TOPIC); MULTIPLE FRACTION RADIOTHERAPY; MULTIPLE MYELOMA; NAUSEA AND VOMITING; ORCHIECTOMY; OSTEOCLAST; OSTEOLYSIS; OVERALL SURVIVAL; PAIN ASSESSMENT; PREGNANCY; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SINGLE FRACTION THERAPY; THROMBOCYTOPENIA; TREATMENT CONTRAINDICATION; TREATMENT DURATION; TREATMENT RESPONSE; VISUAL ANALOG SCALE;

ANIMALS; BONE NEOPLASMS; BRACHYTHERAPY; HUMANS; PAIN; RADIOPHARMACEUTICALS;

EID: 82955162692     PISSN: 10462023     EISSN: 10959130     Source Type: Journal    
DOI: 10.1016/j.ymeth.2011.07.001     Document Type: Review

References (236)

1. Body J.J. Bone 1992, 13(Suppl. 1):S57-S62.
2. Galasko C.S. Clin Orthop 1986, (210):18-30.
3. Bhardwaj S., Holland J.F. Clin Orthop. 1982, (169):28-37.
4. Mantyh P.W., Clohisy D.R., Koltzenburg M., Hunt S.P. Nat. Rev. Cancer 2002, 2(3):201-209.
5. Mundy G.R. Nat. Rev. Cancer 2002, 2(8):584-593.
6. Serafini A.N. Int. J. Radiat. Oncol. Biol. Phys. 1994, 30(5):1187-1194.
7. Nielsen O.S., Munro A.J., Tannock I.F. J. Clin. Oncol. 1991, 9(3):509-524.
8. Rabbani S.A., Gladu J., Harakidas P., Jamison B., Goltzman D. Int. J. Cancer 1999, 80(2):257-264.
9. Garrett I.R. Semin. Oncol. 1993, 20(3 Suppl. 2):4-9.
10. Zhang Y., Fujita N., Oh-hara T., et al. Oncogene 1998, 16(6):693-703.
11. Scher H.I., Yagoda A. Am J Med 1987, 82(2A):6-28.
12. Keller E.T., Zhang J., Cooper C.R., et al. Cancer Metastasis Rev. 2001, 20(3-4):333-349.
13. Magro C., Orr F.W., Manishen W.J., Sivananthan K., Mokashi S.S. J. Natl. Cancer Inst. 1985, 74(4):829-838.
14. Cramer S.F., Fried L., Carter K.J. Cancer 1981, 48(12):2649-2660.
15. Eilon G., Mundy G.R. Cancer Res. 1983, 43(12 Pt. 1):5792-5794.
16. Durie B.G., Salmon S.E., Mundy G.R. Br. J. Haematol. 1981, 47(1):21-30.
17. Ibbotson K.J., Twardzik D.R., D'Souza S.M., Hargreaves W.R., Todaro G.J., Mundy G.R. Science 1985, 228(4702):1007-1009.
18. Hirshorn J.E., Vrhovsek E., Posen S. J. Clin. Endocrinol. Metab. 1979, 48(2):217-221.
19. Bertolini D.R., Nedwin G.E., Bringman T.S., Smith D.D., Mundy G.R. Nature 1986, 319(6053):516-518.
20. Canalis E. Clin. Orthop. 1985, (193):246-263.
21. Byrne T.N. N. Engl. J. Med. 1992, 327(9):614-619.
22. Coleman R.E. Cancer Treat. Rev. 2001, 27(3):165-176.
23. McGuire D.B. J. Pain Symptom Manage. 1992, 7(5):312-319.
24. Caraceni A. Acta Anaesthesiol. Scand. 2001, 45(9):1067-1075.
25. Wallenstein S.L., Heidrich G., Kaiko R., Houde R.W. Br. J. Clin. Pharmacol. 1980, 10(Suppl. 2):319S-327S.
26. Littman G.S., Walker B.R., Schneider B.E. Clin. Pharmacol. Ther. 1985, 38(1):16-23.
27. Caraceni A., Cherny N., Fainsinger R., et al. J. Pain Symptom Manage. 2002, 23(3):239-255.
28. Scott J., Huskisson E.C. Pain 1976, 2(2):175-184.
29. Gracely R.H., McGrath F., Dubner R. Pain 1978, 5(1):5-18.
30. Jensen M.P., Turner J.A., Romano J.M. Pain 1994, 58(3):387-392.
31. Resche I., Chatal J.F., Pecking A., et al. Eur. J. Cancer 1997, 33(10):1583-1591.
32. Palmedo H., Manka-Waluch A., Albers P., et al. J. Clin. Oncol. 2003, 21(15):2869-2875.
33. Liepe K., Hliscs R., Kropp J., Runge R., Knapp F.F., Franke W.G. J. Nucl. Med. 2003, 44(6):953-960.
34. Kraeber-Bodere F., Campion L., Rousseau C., Bourdin S., Chatal J.F., Resche I. Eur. J. Nucl. Med. 2000, 27(10):1487-1493.
35. Farhanghi M., Holmes R.A., Volkert W.A., Logan K.W., Singh A. J. Nucl. Med. 1992, 33(8):1451-1458.
36. Serafini A.N., Houston S.J., Resche I., et al. J. Clin. Oncol. 1998, 16(4):1574-1581.
37. Joyce C.R., Zutshi D.W., Hrubes V., Mason R.M. Eur. J. Clin. Pharmacol. 1975, 8(6):415-420.
38. Price D.D., Bush F.M., Long S., Harkins S.W. Pain 1994, 56(2):217-226.
39. Cleeland C.S. Measurement of pain by subjective report. Advanves in Pain Research and Management, vol. 12, Issues in Pain Management 1989, 391-403. Raven Press, New York. C.R. Chapman, J.D. Loeser (Eds.).
40. Clark W.C., Ferrer-Brechner T., Janal M.N., Carroll J.D., Yang J.C. Pain 1989, 37(1):23-32.
41. Jensen M.P., McFarland C.A. Pain 1993, 55(2):195-203.
42. Portenoy R.K., Kornblith A.B., Wong G., et al. Cancer 1994, 74(3):907-915.
43. Ingham J., Seidman A., Yao T.J., Lepore J., Portenoy R. Qual. Life Res. 1996, 5(5):503-507.
44. Caraceni A., Portenoy R.K. Pain 1999, 82(3):263-274.
45. Melzack R. Pain 1975, 1(3):277-299.
46. Graham C., Bond S.S., Gerkovich M.M., Cook M.R. Pain 1980, 8(3):377-387.
47. Dudgeon D., Raubertas R.F., Rosenthal S.N. J. Pain Symptom Manage. 1993, 8(4):191-195.
48. Mor V., Laliberte L., Morris J.N., Wiemann M. Cancer 1984, 53(9):2002-2007.
49. Schaafsma J., Osoba D. Qual. Life Res. 1994, 3(6):413-424.
50. World Health Organization. Cancer Pain Relief and Palliative Care: Report of a WHO Expert Committee, World Health Organization, Geneva, Switzerland, 1990.
51. Portenoy R.K. Lancet 1992, 339(8800):1026-1031.
52. Paes F.M., Serafini A.N. Semin. Nucl. Med. 2010, 40:89-104.
53. Zlotta A.R., Schulman C.C. World J. Urol. 2000, 18(3):179-182.
54. Auclerc G., Antoine E.C., Cajfinger F., Brunet-Pommeyrol A., Agazia C., Khayat D. Oncologist 2000, 5(1):36-44.
55. Kudachadkar R., O'Regan R.M. CA Cancer J. Clin. 2005, 55(3):145-163.
56. Lipton A. Cancer 1997, 80(8 Suppl.):1668-1673.
57. Rogers M.J., Gordon S., Benford H.L., et al. Cancer 2000, 88(12 Suppl.):2961-2978.
58. Russell R.G., Rogers M.J., Frith J.C., et al. J. Bone Miner. Res. 1999, 14(Suppl. 2):53-65.
59. van beek E., Lowik C., van der Pluijm G., Papapoulos S. J. Bone Miner. Res. 1999, 14(5):722-729.
60. Shipman C.M., Rogers M.J., Apperley J.F., Russell R.G., Croucher P.I. Br. J. Haematol. 1997, 98(3):665-672.
61. Lowik C.W., van der Pluijm G., van der Wee-Pals L.J., van Treslong-de Groot H.B., Bijvoet O.L. J. Bone Miner. Res. 1988, 3(2):185-192.
62. Fromigue O., Lagneaux L., Body J.J. J. Bone Miner. Res. 2000, 15(11):2211-2221.
63. Jagdev S.P., Coleman R.E., Shipman C.M., Rostami H.A., Croucher P.I. Br. J. Cancer 2001, 84(8):1126-1134.
64. Boissier S., Magnetto S., Frappart L., et al. Cancer Res. 1997, 57(18):3890-3894.
65. Boissier S., Ferreras M., Peyruchaud O., et al. Cancer Res. 2000, 60(11):2949-2954.
66. Van Beek E.R., Lowik C.W., Papapoulos S.E. Bone 2002, 30(1):64-70.
67. Berenson J.R., Rosen L.S., Howell A., et al. Cancer 2001, 91(7):1191-1200.
68. van Holten-Verzantvoort A.T., Kroon H.M., Bijvoet O.L., et al. J Clin Oncol 1993, 11(3):491-498.
69. Conte P.F., Latreille J., Mauriac L., et al. J. Clin. Oncol. 1996, 14(9):2552-2559.
70. Rizzoli R., Forni M., Schaad M.A., et al. Bone 1996, 18(6):531-537.
71. Diel I.J., Solomayer E.F., Costa S.D., et al. N. Engl. J. Med. 1998, 339(6):357-363.
72. Powles T., Paterson S., Kanis J.A., et al. J. Clin. Oncol. 2002, 20(15):3219-3224.
73. Saarto T., Blomqvist C., Virkkunen P., Elomaa I. J. Clin. Oncol. 2001, 19(1):10-17.
74. Mason M.D., Sydes M.R., Glaholm J., et al. J. Natl. Cancer Inst. 2007, 99(10):765-776.
75. Heidenreich A., Elert A., Hofmann R. Prostate Cancer Prostatic Dis. 2002, 5(3):231-235.
76. Weinfurt K.P., Anstrom K.J., Castel L.D., Schulman K.A., Saad F. Ann. Oncol. 2006, 17(6):986-989.
77. Mason M.D., Sydes M.R., Glaholm J., Langley R.E., Huddart R.A., Sokal M. J. Natl. Cancer Inst. 2007, 10(99):765-776.
78. Simonet W.S., Lacey D.L., Dunstan C.R., et al. Cell 1997, 89(2):309-319.
79. Clohisy D.R., Ramnaraine M.L., Scully S., et al. J. Orthop. Res. 2000, 18(6):967-976.
80. Morony S., Capparelli C., Sarosi I., Lacey D.L., Dunstan C.R., Kostenuik P.J. Cancer Res. 2001, 61(11):4432-4436.
81. J. Body, P. Greip, R.E. Colemann, et al. Osteoprotegerin prevents bone destruction in athymic and syngeneic models of experimental tumor metastasis to bone. Paper presented at: Third North American Symposium on Skeletal Complications of Malignancy, April 25-27, 2002, Bethesda, MD, 2002 (abstract).
82. Powell G.J., Southby J., Danks J.A., et al. Cancer Res. 1991, 51(11):3059-3061.
83. Guise T.A., Yin J.J., Taylor S.D., et al. J. Clin. Invest. 1996, 98(7):1544-1549.
84. Guise T.A. Cancer 2000, 88(12 Suppl.):2892-2898.
85. Guise T.A., Yin J.J., Thomas R.J., Dallas M., Cui Y., Gillespie M.T. Bone 2002, 30(5):670-676.
86. Lin A., Ray M.E. Cancer Metastasis Rev. 2006, 25(4):669-675.
87. Janjan N. Hematol. Oncol. Clin. North Am. 2006, 20(1):187-211.
88. Agarawal J.P., Swangsilpa T., van der Linden Y., Rades D., Jeremic B., Hoskin P.J. Clin. Oncol. (R. Coll. Radiol.) 2006, 18(10):747-760.
89. Saarto T., Janes R., Tenhunen M., Kouri M. Eur. J. Pain 2002, 6(5):323-330.
90. Steenland E., Leer J.W., van Houwelingen H., et al. Radiother. Oncol. 1999, 52(2):101-109.
91. Gaze M.N., Kelly C.G., Kerr G.R., et al. Radiother. Oncol. 1997, 45(2):109-116.
92. Nielsen O.S., Bentzen S.M., Sandberg E., Gadeberg C.C., Timothy A.R. Radiother. Oncol. 1998, 47(3):233-240.
93. Uppelschoten J.M., Wanders S.L., de Jong J.M. Radiother. Oncol. 1995, 36(3):198-202.
94. Arcangeli G., Micheli A., Giannarelli D., et al. Radiother. Oncol. 1989, 14(2):95-101.
95. Blitzer P.H. Cancer 1985, 55(7):1468-1472.
96. Arcangeli G., Giovinazzo G., Saracino B., D'Angelo L., Giannarelli D., Micheli A. Int. J. Radiat. Oncol. Biol. Phys. 1998, 42(5):1119-1126.
97. Ratanatharathorn V., Powers W.E., Moss W.T., Perez C.A. Int. J. Radiat. Oncol. Biol. Phys. 1999, 44(1):1-18.
98. Tong D., Gillick L., Hendrickson F.R. Cancer 1982, 50(5):893-899.
99. Kuban D.A., Delbridge T., el-Mahdi A.M., Schellhammer P.F. J. Urol. 1989, 141(3):572-574.
100. Salazar O.M., Rubin P., Hendrickson F.R., et al. Cancer 1986, 58(1):29-36.
101. Quilty P.M., Kirk D., Bolger J.J., et al. Radiother. Oncol. 1994, 31(1):33-40.
102. Breen S.L., Battista J.J. Phys. Med. Biol. 2000, 45(4):879-896.
103. Akabani G. J. Nucl. Med. 1993, 34(8):1361-1366.
104. Spiers F.W., Beddoe A.H., Whitwell J.R. Br. J. Radiol. 1978, 51(608):622-627.
105. Blake G.M., Zivanovic M.A., McEwan A.J., Condon B.R., Ackery D.M. Br. J. Radiol. 1987, 60(711):253-259.
106. Breen S.L., Powe J.E., Porter A.T. J. Nucl. Med. 1992, 33(7):1316-1323.
107. Hosain F., Spencer R.P. Semin. Nucl. Med. 1992, 22(1):11-16.
108. Pecher P. Univ. CA Publications Pharmacol. 1942, 2:117-149.
109. Silberstein E.B., Williams C. J. Nucl. Med. 1985, 26(4):345-348.
110. Laing A.H., Ackery D.M., Bayly R.J., et al. Br. J. Radiol. 1991, 64(765):816-822.
111. Crawford E.D., Kozlowski J.M., Debruyne F.M., et al. Urology 1994, 44(4):481-485.
112. Porter A.T., Ben-Josef E. Important Adv. Oncol. 1995, 1:87-94.
113. Pons F., Herranz R., Garcia A., et al. Eur. J. Nucl. Med. 1997, 24(10):1210-1214.
114. Kasalicky J., Krajsk V. Eur. J. Nucl. Med. 1998, 25(10):1362-1367.
115. Fuster D., Herranz D., Vidal-Sicart S., et al. Nucl. Med. Commun. 2000, 21(7):623-626.
116. Ma Y.B., Yan W.L., Dai J.C., Xu F., Yuan Q., Shi H.H. Zhonghua Nan Ke Xue 2008, 14(9):819-822.
117. Liepe K., Runge R., Kotzerke J. Am. J. Hosp. Palliat. Care 2005, 22(6):457-464.
118. Robinson R.G., Blake G.M., Preston D.F., et al. Radiographics 1989, 9(2):271-281.
119. Robinson R.G., Preston D.F., Schiefelbein M., Baxter K.G. JAMA 1995, 274(5):420-424.
120. Porter A.T., Davis L.P. Oncology (Huntingt) 1994, 8(2):93-96. discussion 96, 99-101.
121. McEwan A.J., Amyotte G.A., McGowan D.G., MacGillivray J.A., Porter A.T. Eur. Urol. 1994, 26(Suppl. 1):26-31.
122. Mertens W.C., Stitt L., Porter A.T. Am. J. Clin. Oncol. 1993, 16(3):238-242.
123. Finlay I.G., Mason M.D., Shelley M. Lancet Oncol. 2005, 6(6):392-400.
124. Schmeler K., Bastin K. Hosp. J. 1996, 11(2):1-10.
125. Dafermou A.F., Colamussi P.F., Giganti M.F., Cittanti C.F., Bestagno M.F., Piffanelli A. Eur. J. Nucl. Med. 2001, 28(7):788-798. 2001(7), 788-798.
126. Liepe K., Franke W.G., Kropp J., Koch R., Runge R., Hliscs R. Nuklearmedizin 2000, 39(6):146-151.
127. Liepe K., Kotzerke J. Nucl. Med. Commun. 2007, 28:623-630.
128. Ben-Josef E., Maughan R.L., Vasan S., Porter A.T. Nucl. Med. Commun. 1995, 16(6):452-456.
129. Nilsson S., Larsen R.H., Fossa S.D., et al. Clin. Cancer Res. 2005, 11(12):4451-4459.
130. Nilsson S., Franzen L., Parker C., et al. Lancet Oncol. 2007, 8(7):587-594.
131. Nilsson S., Strang P., Franzen L., et al. EJC Suppl. 2009, 7. Abs P-7011.
132. Parker C., Hoskin P., Pscoe S., Chodack A., O'Sullivan J.M., Germa J.R., Lokna A. EJC Suppl. 2009, 7. Abs O-7003.
133. Silberstein E.B. Semin. Oncol. 1993, 20(3 Suppl. 2):10-21.
134. Pandit-Taskar N., Batraki M., Divgi C.R. J. Nucl. Med. 2004, 45(8):1358-1365.
135. Friedell H.L., Storaasli J.P. AJR 1950, 64:559-575.
136. Silberstein E.B., Elgazzar A.H., Kapilivsky A. Semin. Nucl. Med. 1992, 22(1):17-27.
137. Nair N. J. Nucl. Med. 1999, 40(2):256-261.
138. Fettich J., Padhy A.K., Nair N., Moralles R. W. J. Nucl. Med. 2003, 2:226-231.
139. Fettich J., Padhy A.K., Nair N., Morales R. W. J. Nucl. Med. 2003, 2:226-231.
140. Maxfield J.R., Maxfield J.G., Maxfield W.S. South Med. J. 1958, 51(3):320-327.
141. Stoff J.S. Am. J. Med. 1982, 72(3):489-495.
142. Tong E.C., Finkelstein P. J. Urol. 1973, 109(1):71-75.
143. Landaw S.A. Semin. Hematol. 1986, 23(2):156-165.
144. Spiers F.W., Beddoe A.H., King S.D. Br. J. Radiol. 1976, 49(578):133-140.
145. Turner J.H., Martindale A.A., Sorby P., et al. Eur. J. Nucl. Med. 1989, 15(12):784-795.
146. Maxon H.R., Deutsch E.A., Thomas S.R., et al. Radiology 1988, 166(2):501-507.
147. Palmedo H., Guhlke S., Bender H., et al. Eur. J. Nucl. Med. 2000, 27(2):123-130.
148. Blower P.J., Kettle A.G., O'Doherty M.J., Coakley A.J., Knapp F.F. Eur. J. Nucl. Med. 2000, 27(9):1405-1409.
149. Kutzner J., Grimm W., Brod K.H., Roesler A. Dtsch. Med. Wochenschr. 1982, 107(36):1360-1361.
150. Eisenhut M., Berberich R., Kimmig B., Oberhausen E. J. Nucl. Med. 1986, 27(8):1255-1261.
151. Liepe K., Kropp J., Runge R., Kotzerke J. Br. J. Cancer 2003, 89(4):625-629.
152. Atkins H.L., Mausner L.F., Srivastava S.C., Meinken G.E., Cabahug C.J., D'Alessandro T. J. Nucl. Med. 1995, 36(5):725-729.
153. de Klerk J.M., Zonnenberg B.A., van het Schip A.D., et al. Eur. J. Nucl. Med. 1994, 21(10):1114-1120.
154. de Klerk J.M., van het Schip A.D., Zonnenberg B.A., et al. J. Nucl. Med. 1996, 37(2):244-249.
155. Maxon H.R., Schroder L.E., Thomas S.R., et al. Radiology 1990, 176(1):155-159.
156. Han S.H., de Klerk J.M., Tan S., et al. J. Nucl. Med. 2002, 43(9):1150-1156.
157. Lam M.G., de Klerk J.M., van Rijk P.P. Eur. J. Nucl. Med. Mol. Imaging 2004, 31(Suppl. 1):S162-S170.
158. Palmedo H., Bender H., Dierke-Dzierzon C., et al. Clin. Nucl. Med. 1999, 24(9):643-648.
159. Maxon H.R., Schroder L.E., Hertzberg V.S., et al. J. Nucl. Med. 1991, 32(10):1877-1881.
160. Bodei L., Lam M., Chiesa C., et al. Eur. J. Nucl. Med. Mol. Imaging 2008, 35(10):1934-1940.
161. Liepe K., Kropp J., Hliscs R., Franke W.G. Clin. Nucl. Med. 2000, 25(11):901-904.
162. Maxon H.R., Thomas S.R., Hertzberg V.S., et al. Semin. Nucl. Med. 1992, 22(1):33-40.
163. Turner J.H., Claringbold P.G., Hetherington E.F., Sorby P.F., Martindale A.A. J. Clin. Oncol. 1989, 7(12):1926-1931. 1989(12), 1926-1931.
164. Turner J.H., Claringbold P.G. Eur. J. Cancer 1991, 27(9):1084-1086.
165. Collins C.F., Eary J.F., Donaldson G.F., et al. J. Nucl. Med. 1993, 34(11):1839-1844. 1993(11), 1839-1844.
166. Sartor O., Reid R.H., Hoskin P.J., et al. Urology 2004, 63(5):940-945.
167. Deng H.F., Luo S.F., Tan T.F., et al. Hua Xi Yi Ke Da Xue Xue Bao 1995, 26(4):391-394. 1995(4), 391-394.
168. Tian J.H., Zhang J.M., Hou Q.T., et al. Eur. J. Nucl. Med. 1999, 26(1):2-7.
169. Enrique O., Zhonyun P., Prma E.P., et al. World J. Nucl. Med. 2002, 1:21-27.
170. A.J. Paravati, A.L. Russo, C. Aitken, Int. J. Radiat. Oncol. Biol. Phys., in press.
171. Bayouth J.E., Macey D.J., Kasi L.P., Fossella F.V. J. Nucl. Med. 1994, 35(1):63-69.
172. Bartlett M.L., Webb M., Durrant S., Morton A.J., Allison R., Macfarlane D.J. Eur. J. Nucl. Med. Mol. Imaging 2002, 29(11):1470-1477.
173. Singh A.F., Holmes R.A., Farhangi M.F., et al. J. Nucl. Med. 1989, 30(11):1814-1818. 1989(11), 1814-1818.
174. Turner J.H., Claringbold P.G., Hetherington E.L., Sorby P., Martindale A.A. J. Clin. Oncol. 1989, 7(12):1926-1931.
175. Eary J.F., Collins C.F., Stabin M.F., et al. J. Nucl. Med. 1993, 34(7):1031-1036. 1993(7), 1031-1036.
176. Lambert B., Bacher K., Defreyne L., et al. J. Nucl. Med. 2005, 46(1):60-66.
177. Liepe K., Brogsitter C., Leonhard J., et al. Jpn. J. Clin. Oncol. 2007, 37(12):942-950.
178. Liepe K., Zaknun J.J., Soroa V.E., Barrenechea E., Shrikant S., Jeong J.M. Eur. J. Nucl. Med. 2007, 34(Suppl. 1):476.
179. Okuda K., Ohtsuki T., Obata H., et al. Cancer 1985, 56(4):918-928.
180. Bunjes D., Buchmann I., Duncker C., et al. Blood 2001, 98(3):565-572.
181. Wohrle J., Nusser T., Krause B.J., et al. Nuklearmedizin 2007, 46(5):185-191.
182. Cho Y.S., Kim M.A., Hwang K.K., et al. Catheter Cardiovasc. Interv. 2004, 63(3):274-281.
183. Reynen K., Kockeritz U., Kropp J., et al. Int. J. Cardiol. 2004, 95(1):29-34.
184. Hsieh B.T., Hsieh J.F., Tsai S.C., Lin W.Y., Wang S.J., Ting G. Nucl. Med. Biol. 1999, 26(8):973-976.
185. Maxon H.R., Schroder L.E., Washburn L.C., et al. J. Nucl. Med. 1998, 39(4):659-663.
186. Lin W.Y., Hsieh J.F., Lin C.P., et al. Nucl. Med. Biol. 1999, 26(4):455-459.
187. Li S., Liu J., Zhang H., Tian M., Wang J., Zheng X. Clin. Nucl. Med. 2001, 26(11):919-922.
188. Lam M.G.H., Bosma T.B., van Rijk P.P., Zonneberg B.A. Eur. J. Nucl. Med. Mol. Imaging 2009, 36:1425-1433.
189. Savio E., Gaudiano J., Robles A.M., et al. BMC Nucl. Med. 2001, 1(1):2.
190. Srivastava S.C., Atkins H.L., Krishnamurthy G.T., et al. Clin. Cancer Res. 1998, 4(1):61-68.
191. Baczyk M., Czepczynski R., Milecki P., Pisarek M., Oleksa R., Sowinski J. Nucl. Med. Commun. 2007, 28(4):245-250.
192. Lambert B., de Klerk J.M. Nucl. Med. Commun. 2006, 27(3):223-229.
193. Liepe K., Kotzerke J. Nucl. Med. Commun. 2007, 28(8):623-630.
194. Ben-Josef E., Lucas D.R., Vasan S., Porter A.T. Nucl. Med. Commun. 1995, 16(6):457-463.
195. Liepe K., Geidel H.H., Bergmann R., Haase M., Runge R., Kotzerke J. Nucl. Med. Commun. 2009, 30(9):693-699.
196. Tu S.M., Millikan R.E., Mengistu B., et al. Lancet 2001, 357(9253):336-341.
197. Ricci S., Boni G., Pastina I., et al. Eur. J. Nucl. Med. 2007, 34(7):1023-1030.
198. Fizazi K., Beuzeboc P., Lumbroso J., et al. J. Clin. Oncol. 2009, 27(15):2429-2435.
199. Lam M.G., de Klerk J.M., Zonnenberg B.A. J. Palliat. Med. 2009, 12(7):649-651.
200. Giammarile F., Mognetti T., Blondet C., Desuzinges C., Chauvot P. J. Nucl. Med. 1999, 40(4):585-590.
201. EANM Procedure Guidelines for Treatment of Refractory Metastatic Bone Pain, Eur. J. Nucl. Med. 30(3) (2003) BP7-BP11.
202. Soerdjbalie-Maikoe V., Pelger R.C., Lycklama a Nijeholt G.A., et al. Eur. J. Nucl. Med. Mol. Imaging 2002, 29(4):494-498.
203. Mertens W.C., Porter A.T., Reid R.H., Powe J.E. J. Nucl. Med. 1992, 33(8):1437-1443.
204. Sciuto R., Festa A., Rea S., et al. J. Nucl. Med. 2002, 43(1):79-86.
205. Sciuto R., Maini C.L., Tofani A., Fiumara C., Scelsa M.G., Broccatelli M. Nucl. Med. Biol. 1996, 17(9):799-804.
206. Tu S.M., Delpassand E.S., Jones R.F., Amato R., Ellerhorst J., Logothetis C.J. Urol. Oncol. 1996, (2):191-197.
207. Pagliaro L.C., Delpassand E.S., Williams D., Millikan R.E., Tu S.M., Logothetis C.J. Cancer 2003, 97(12):2988-2994.
208. Tu S.M., Kim J., Pagliaro L.C., et al. J. Clin. Oncol. 2005, 23(31):7904-7910.
209. Akerley W., Butera J., Wehbe T., et al. Cancer 2002, 94(6):1654-1660.
210. Nilsson S., Strang P., Ginman C., et al. J. Pain Symptom Manage. 2005, 29(4):352-357.
211. Amato R.J., Hernandez-McClain J., Henary H. Am. J. Clin. Oncol. 2008, 31(6):532-538.
212. Ricci S., Boni G., Pastina I., et al. Eur. J. Nucl. Med. Mol. Imaging 2007, 34(7):1023-1030.
213. Pecherstorfer M., Schilling T., Janisch S., et al. J. Nucl. Med. 1993, 34(7):1039-1044.
214. Roudier M.P., Vesselle H., True L.D., et al. Clin. Exp. Metastasis 2003, 20(2):171-180.
215. Marcus C.S., Saeed S., Mlikotic A., et al. Clin. Nucl. Med. 2002, 27(6):427-430.
216. Flanagan A.M., Chambers T.J. Bone Miner. 1989, 6(1):33-43.
217. Boonekamp P.M., van der Wee-Pals L.J., van Wijk-van Lennep M.M., Thesing C.W., Bijvoet O.L. Bone Miner. 1986, 1(1):27-39.
218. Storto G., Klain M., Paone G., et al. Bone 2006, 39(1):35-41.
219. Smeland S., Erikstein B., Aas M., Skovlund E., Hess S.L., Fossa S.D. Int. J. Radiat. Oncol. Biol. Phys. 2003, 56(5).
220. Fizazi K., Yang J., Peleg S., et al. Clin. Cancer Res. 2003, 9(7):2587-2597.
221. Kakonen S.M., Selander K.S., Chirgwin J.M., et al. J. Biol. Chem. 2002, 277(27):24571-24578.
222. Nakamura T., Hanada K., Tamura M., et al. Endocrinology 1995, 136(3):1276-1284.
223. Harari P.M., Huang S.M. Semin. Radiat. Oncol. 2002, 12(Suppl. 2):21-26.
224. Chinnaiyan P., Huang S., Armstrong E., Harari P.M. Int. J. Radiat. Oncol. Biol. Phys. 2003, 57(2 Suppl.):S294.
225. Farooqui M., Li Y., Rogers T., et al. Br. J. Cancer 2007, 97(11):1523-1531.
226. Farooqui M., Geng Z.H., Stephenson E.J., Zaveri N., Yee D., Gupta K. Mol. Cancer Ther. 2006, 5(3):611-620.
227. Milowsky M.I., Nanus D.M., Kostakoglu L., Vallabhajosula S., Goldsmith S.J., Bander N.H. J. Clin. Oncol. 2004, 22(13):2522-2531.
228. Vallabhajosula S., Kuji I., Hamacher K.A., et al. J. Nucl. Med. 2005, 46(4):634-641.
229. O'Sullivan J.M., McCready V.R., Flux G., et al. Br. J. Cancer 2002, 86(11):1715-1720.
230. Anderson P.M., Wiseman G.A., Dispenzieri A., et al. J. Clin. Oncol. 2002, 20(1):189-196.
231. Eary J.F., Collins C., Stabin M., et al. J. Nucl. Med. 1993, 34(7):1031-1036.
232. Liepe K., Runge R., Kotzerke J. J. Cancer Res. Clin. Oncol. 2005, 131(1):60-66.
233. O'Sullivan J.M., Norman A.R., McCready V.R., et al. Eur. J. Nucl. Med. Mol. Imaging 2006, 33(9):1055-1061.
234. Lam A.S., De Klerk J.M., Zonnenberg B.A. J. Palliat. Med. 2009, 12:649-651.
235. Sciuto R., Tofani A., Festa A., Giannarelli D., Pasqualoni R., Maini C.L. J. Nucl. Med. 2000, 41(4):647-654.
236. Srivastava S. IJNM 2004, 19(3):89-97.